Blog
909 Articles
A Registry for Those at Risk for Pancreatic Cancer
Dr. Robert Kurtz founded the Pancreatic Tumor Registry at Memorial Sloan Kettering to learn more about the genetic mutations that cause pancreatic cancer.
New Drug for BRCA Carriers with Advanced Cancer
A phase I clinical trial is testing the effectiveness of a platinum-based drug for BRCA carriers with pancreatic, breast, and other cancers.
Let’s Win Inducted into the PR News Platinum Hall of Fame
Let’s Win has been inducted into the PR News Platinum Hall of Fame. Other inductees include the ALS Association’s ice bucket challenge.
Celebrating My 5th Anniversary As a Survivor
Scott Hirshey traveled from Detroit to Houston for a Whipple procedure to work with doctors who have expertise in treating pancreatic cancer.
New Cancer Stem Cell Pathway Drug May Change Standard of Care
Dr. Tanios Bekaii-Saab is testing a new drug that works on pancreatic cancer stem cells to make chemotherapy more effective.
More Effective Focused Radiation Therapy and Chemotherapy for Locally Advanced Pancreatic Cancer
A clinical trial tests whether adding Zometa makes chemotherapy and stereotactic body radiation therapy (SBRT) more effective against pancreatic cancer.
Far More Time than I Originally Expected
After a Whipple procedure, SBRT, and chemotherapy, Robert Glazier is staying informed about treatment options for pancreatic cancer.
A Newly Identified Biomarker Panel Shows Promise in Earlier Pancreatic Cancer Detection
The first pancreatic cancer blood test may soon be a reality, as a biomarker panel from the lab of Dr. Ken Zaret shows promise in early testing.
Presurgical Treatment for Pancreatic Cancer That Is Removable
A clinical trial looks at immunotherapy plus vitamin D plus standard chemotherapy before surgery to remove pancreatic cancer.
Pancreatic Cancer Caught Early by Chance
Sandra Wilke chose her pancreatic cancer treatment of chemotherapy and pancreatectomy with an eye to her quality of life. She joined the tumor registry to learn more and help others.
Taking Nothing For Granted
After Whipple surgery and chemoradiation, Susan Zbacnik had molecular profiling, genetic testing, and joined an Immunotherapy clinical trial.
Most Cancer Mutations Are Random DNA Mistakes
In a large study, Dr. Bert Vogelstein of Johns Hopkins found that a majority of cancers, including pancreatic cancer, are caused by random mutations of DNA.
Trying a New Type of Treatment to Stop Advanced Pancreatic Cancer
Researchers test the chemotherapy combination of AM0010 and FOLFOX as a second-line therapy for people with metastatic pancreatic cancer.
Hope and a Chance to Fight
Irwin Greenblatt just wanted a chance, so after Whipple surgery he agreed to join a chemotherapy clinical trial. His wife Audrey tells their story.
An Immunotherapy Game Changer
Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.